Amyris, Inc. (AMRS) 是一家上市公司 属于 基础材料 板块，经营于 Chemicals - Specialty 行业. 公司总部位于 EmeryVille, CA, 美国. 现任CEO为 Hermanus Kieftenbeld.
AMRS 拥有 IPO日期为 2010-09-28, 1,598 名全职员工, 在 NASDAQ Global Select.
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.
